-
Patient-Reported Outcomes As Important Predictors of Apremilast Persistence: A Pooled Analysis of Real-World Data
Mar 10, 2025, 14:00 PM -
Combining Patient Clustering and Quantitative Benefit-Risk Assessment in the Comparison of Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention
Mar 10, 2025, 14:00 PM -
Economic Burden of HER2+ Breast Cancer and the Targeted Therapies Epidemiological & Economic Impact in Trinidad and Tobago
Mar 10, 2025, 14:00 PM -
Cost-Utility Analysis of Sequential Therapy of iCT IRd and DRd strategy for Newly Diagnosed Multiple Myeloma Patients Who are Transplant-Ineligible in China
Mar 10, 2025, 14:00 PM -
Impact Analysis of Statin Discontinuation on Healthcare Resource Utilization (HCRU) and Cost of Care in Patients With Atherosclerotic Cardiovascular Disease (ASCVD) in the US
Mar 10, 2025, 14:00 PM -
Hospital Budget Impact Model of Patterned Frequency-Modulated Oral Stimulation in Preterm Infants
Mar 10, 2025, 14:00 PM -
Budget Impact Analysis of Venetoclax Combination Therapies for the Treatment of Newly Diagnosed Acute Myeloid Leukemia Patients Who Are Aged 75 Years or Older, or Who Have Comorbidities That Preclude Use of Intensive Induction Chemotherapy
Mar 10, 2025, 14:00 PM -
Tailoring Generalized Cost-Effectiveness Analysis (GCEA) to the U.S. Setting: the Importance of Using the Right Prices
Mar 10, 2025, 14:00 PM -
Information-Seeking Behavior of the Hungarian Population Regarding Lung Cancer: A Digital Epidemiological Study Using Google Trends™
Mar 10, 2025, 14:00 PM -
The Clinical Value and Cost-Effectiveness of DefenCath for Reducing Catheter-Related Bloodstream Infections in Adult Patients Receiving Hemodialysis Through a Central Venous Catheter
Mar 10, 2025, 14:00 PM -
Do Framing and Attribute Number Influence Choice Consistency in a Preference-Based Value Assessment of Equity and Efficiency?
Mar 10, 2025, 14:00 PM -
Effectiveness of Digital Care Platforms for Cancer Patients: A Systematic Review and Meta-Analysis
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization And Costs Following Disease Progression With First-Line Systemic Therapy In Patients With Advanced Endometrial Cancer in the US
Mar 10, 2025, 14:00 PM -
Real-World Economic and Clinical Burden of Worsening Heart Failure in the US: Administrative Claims Database Analysis
Mar 10, 2025, 14:00 PM -
Real World Treatment Patterns, Genetic Testing, and Clinical Outcomes among Patients with mCRPC Treated with Olaparib Monotherapy in US Urology Clinics
Mar 10, 2025, 14:00 PM -
Cost-Utility Analysis of Migraine Prevention Treatments for Chronic Migraine Headaches Patients in the United States
Mar 10, 2025, 14:00 PM -
Use of Patient Support Program Data for Real-World Evidence Generation: Opportunities and Pitfalls Illustrated in a Case Study Assessing Trastuzumab Deruxtecan Among Patients With Breast Cancer
Mar 10, 2025, 14:00 PM -
Economic Evaluation of Detection, Treatment, and Prevention Interventions for Perinatal Mood and Anxiety Disorders: A Systematic Literature Review
Mar 10, 2025, 14:00 PM -
Market Size and Dispensing Patterns for Rheumatoid Arthritis Medications in SUS (Brazil, 2019–2023)
Mar 10, 2025, 14:00 PM -
Regional Differences in IVF Utilization Rates in Hungary in the Last Decade
Mar 10, 2025, 14:00 PM
